Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease
Delphine Lebon, Adèle Dujardin, Alexis Caulier, Magalie Joris, A Charbonnier, Bérengère Gruson, Marine Quint, Sandrine Castelain, Catherine François, Marie-Noëlle Lacassagne, Nicolas Guillaume, Jean‐Pierre Marolleau, P. Morel
Topics & Concepts
RuxolitinibMedicineInternal medicineHazard ratioAdverse effectHematopoietic stem cell transplantationViral loadGraft-versus-host diseaseImmunologyCytomegalovirusJanus kinase inhibitorTransplantationCohortGastroenterologyVirusJanus kinaseViral diseaseHerpesviridaeConfidence intervalBone marrowMyelofibrosisCytokineHematopoietic Stem Cell TransplantationCytomegalovirus and herpesvirus researchViral-associated cancers and disorders